1. Labor S, Dalbello Tir AM, Plavec D, Juric I, Roglic M, Pavkov Vukelic J, Labor M. What is safe enough - asthma in pregnancy - a review of current literature and recommendations. Asthma Res Pract. 2018 Dec 27;4:11. doi: 10.1186/s40733-018-0046-5.
2. National Health Service. Asthma in Pregnancy Guideline. Greater Manchester and Eastern Cheshire and Strategic Clinical Networks. 2019. https://www.england.nhs.uk/north-west/wp-content/uploads/sites/48/2019/12/GMEC-Asthma-Care-in-Pregnancy-guideline-Final-V1.0-18.10.2019.pdf
3. Abdullah K, Zhu J, Gershon A, Dell S, To T. Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study. Eur Respir J. 2020 Feb 12;55(2):1901335. doi: 10.1183/13993003.01335-2019.
4. Middleton PG, Gade EJ, Aguilera C. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J. 2020 Feb 6;55(2):1901208. doi: 10.1183/13993003.01208-2019.
5. British Thoracic Society. British guideline on the management of asthma. NHS Scotland. 2019.
6. Blais L, Kettani F-Z, Forget A, Beauchesne M-F, Lemière C. Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort. Thorax. 2015; 70(7): 647–52. https://www.ncbi.nlm.nih.gov/pubmed/25888364
7. Howley MM, Papadopoulos EA, Van Bennekom CM, et al; National Birth Defects Prevention Study. Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997-2011. J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3490-3499.e9. doi: 10.1016/j.jaip.2020.07.033.
8. Garne E, Vinkel Hansen A, Morris J, et al. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study. BJOG. 2016 Sep;123(10):1609-18. doi: 10.1111/1471-0528.14026.
9. Lin S, Munsie JP, Herdt-Losavio ML, et al. Maternal asthma medication use and the risk of selected birth defects. Pediatrics. 2012;129(2):317–24.
10. Kallen B. Maternal Asthma and Use of Antiasthmatic Drugs in Early Pregnancy and Congenital Malformations in the Offspring. J Pulm Respir Med. 2014; 04(01). https://www.omicsonline.org/open-access/maternal-asthma-and-use-of-antiasthmatic-drugs-in-early-pregnancy-and-congenital-malformations-in-the-offspring-2161-105X.1000166.php?aid=22473
11. Charlton RA, Snowball JM, Nightingale AL, Davis KJ. Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study. J Allergy Clin Immunol Pract. 2015; 3(5):772-779.e3. https://www.ncbi.nlm.nih.gov/pubmed/26116951
12. Eltonsy S, Forget A, Beauchesne MF, et al. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy. J Allergy Clin Immunol. 2015 Jan;135(1):123-30. doi: 10.1016/j.jaci.2014.07.051.
13. Gregersen TL, Ulrik CS. Safety of bronchodilators and corticosteroids for asthma during pregnancy: what we know and what we need to do better. J Asthma Allergy. 2013 Nov 15;6:117-25. doi: 10.2147/JAA.S52592.
14. Global Initiative for Asthma. Global Strategy For Asthma Management And Prevention. 2019. https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf